NEWS DESK
Building your stock news briefing…
Cloudflare, Inc. Class A Common Stock (NET) is currently showing a bullish headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently mixed earnings tone.
SEATTLE, June 03, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that the first meningioma patient was dosed with [212Pb]VMT-α-NET in the Company's ongoing Phase 1/2a study.
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
Trading Symbol: TSX/NYSE AMERICAN: SVM VANCOUVER, BC, May 26, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for the three months ("Q4 Fiscal 2026") and twelve months ("Fiscal 2026") ended March 31, 2026. All amounts are expressed in US dollars, and figures may not add due to rounding.
This section is separated from the general news feed so investors can quickly connect the latest headlines with the structured earnings report.
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
Trading Symbol: TSX/NYSE AMERICAN: SVM VANCOUVER, BC, May 26, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for the three months ("Q4 Fiscal 2026") and twelve months ("Fiscal 2026") ended March 31, 2026. All amounts are expressed in US dollars, and figures may not add due to rounding.
Cloudflare, Inc. Class A Common Stock (NET) is currently trading in a mixed range, reflecting a balanced market sentiment despite a relatively bullish news score of 68. The leading coverage centers on advances in medical therapies involving the NET biomarker, such as Perspective Therapeutics dosing the first patient in a Phase 1/2a study with an innovative treatment, which while not directly related to Cloudflare, shares the NET ticker and might trigger some attention. Cloudflare’s own earnings tone is mixed and its price position versus moving averages is neutral, indicating no clear directional momentum at this time. Traders might be watching for clearer earnings signals or shifts in technical indicators to determine future trend direction.
NET is not giving a fully clean trend read right now, which makes the quality of follow-through especially important.
Momentum is not especially stretched right now, so price behaviour around fresh headlines may matter more than an extreme oscillator reading.
Last price is $261.14, versus MA50 at — and MA200 at —. Relative to those reference points, NET is — vs MA50 and — vs MA200.
SEATTLE, June 03, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that the first meningioma patient was dosed with [212Pb]VMT-α-NET in the Company's ongoing Phase 1/2a study.
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
Trading Symbol: TSX/NYSE AMERICAN: SVM VANCOUVER, BC, May 26, 2026 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp" or the "Company") (TSX: SVM) (NYSE American: SVM) reported its financial and operating results for the three months ("Q4 Fiscal 2026") and twelve months ("Fiscal 2026") ended March 31, 2026. All amounts are expressed in US dollars, and figures may not add due to rounding.